Report Overview

According to the deep-dive market assessment study by Growth Plus Reports, the global medical swabs market was valued at US$ 2.78 billion in 2021 and is expected to register a revenue CAGR of 6.50% to reach US$ 4.89 billion by 2030.

Market Fundamentals 

Medical swabs are used to collect biological specimens, transport microorganisms, and preserve samples. The tips of medical swabs are covered with cotton, and the ends are made of plastic or wood. Non-sterile collection swabs are used for non-invasive procedures such as wound debridement, skin cleaning, and so on. In contrast, sterile medical swabs are used for virus transport using media. The most common uses for medical swabs are microorganism isolation in culture media and non-invasive sample collection procedures such as nasal swabs and throat swabs. During the COVID-19 pandemic, samples were collected from the throat and nasal passages for RTPCR and rapid testing. 

[8748935]

Market Dynamics

The global medical swabs market revenue growth is driven by the emerging diagnostics industry and hospital industry and the prevalence of infectious diseases such as COVID-19, H1N1, pneumonia, and tuberculosis. Additionally, technological advancement, the introduction of a novel product, and the increasing number of key players are contributing to the revenue growth of the global medical swabs market. However, the lack of medical swabs during the COVID-19 pandemic and the misconception that nasopharyngeal swabs damage the brain barrier slowed the market’s revenue growth. However, as COVID-19 cases have decreased, this issue is resolved.

Market Ecosystem

The global medical swabs market is analyzed from four perspectives: types, applications, end-user, and region. 

Medical Swabs Market by Type

[657456345]

The global medical swabs market is segmented based on types: foam-tipped, non-woven, cotton, and others. 

Cotton-tipped medical swabs are leading the global medical swabs market owing to the high prevalence of COVID-19, affordable price, and a substantial number of key players. Additionally, the high hospital and diagnostic services demand is fueling the global cotton-tipped medical swabs market. Moreover, increasing demand for personal hygiene products such as cotton earbuds, cotton wipes, and cotton pads are also fueling the revenue growth of the global cotton medical swabs market.

Medical Swabs Market by Application

Based on application, the global medical swabs market is segmented into disinfection, specimen collection, and others. 

The specimen collection segment is leading the global medical swabs market owing to most diseases such as COVID-19, H1N1 is needed for a sample collection from the nasopharynx due to the highest viral load in the area, which can be accessible by specimen collection swabs. Additionally, the increasing prevalence of respiratory diseases such as COVID-19, pneumonia, and influenza contribute to the revenue growth of the global specimen collection medical swabs market. 

Medical Swabs Market by End User

Based on end-user, the global medical swabs market is segmented into hospitals & clinics, research institutes, and laboratories & diagnostic centers. The hospitals and clinics segment is leading the global medical swabs market owing to increasing patient footfall for diagnosis and treatment and the increasing prevalence of chronic and infectious diseases. Additionally, increasing surgical procedures and swift adoption of novel diagnostic techniques are contributing to the revenue growth of the hospitals and clinics medical swabs market.

Medical Swabs Market by Region

Based on region, the global medical swabs market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. 

North America dominates the global medical swabs market, followed by the Asia Pacific. The large revenue share of North America can be attributed to the region's high prevalence of infectious diseases and a high number of key players. Additionally, technological advancement increases healthcare expenditure and developed infrastructure. 

The Asia Pacific is also expected to register exponential revenue growth in the global medical swabs market owing to the adoption of technology, large population, emerging diagnostic industry, and prevalence of infectious diseases.

Competitive Landscape

The prominent players operating in the global medical swabs market are:

• Becton, Dickinson, and Company
• 3M Company
• Copan Diagnostics Inc. 
• FL MEDICAL srl 
• DLS Medical
• Dynarex 
• Advacare Pharma
• Puritan Medical Products
• C. R. Bard, Inc.
• Thermo Fisher Scientific
• Puritan Medical Products
• Medical Wire& Equipment
• COPAN Diagnostics
• Titan Biotech Ltd.
• YOCON Biology
• Quidel Corporation

Strategic Developments

• In April 2020, Resolution medical launched 3D print carbon DLS technology nasopharyngeal swabs for COVID-19 testing.
• In February 2022, Rhinostics and Nexus Medical Laboratories Announce Collaboration to Launch Rapid, Cost-Effective Swab Sample Processing for Telehealth and Other Industries. Nexus Medical Labs will use the RHINOsticTM Automated Nasal Swab to improve swab-based laboratory testing efficiencies, increase throughput, lower labor costs, provide the quickest turnaround times, and produce better COVID-19 and other analyte testing results.
• In May 2022, Nexus Medical Labs received approval from USFDA for Emergency Use Authorization for SARS-CoV-2 Testing Using the RHINOstic™ Automated Nasal Swab collection device. RHINOstic™ Automated Swab collection device comes with a unique swab head design and active cap that helps with accessioning, de-capping, elution, and preparation of the assay plate for polymerase chain reaction (PCR), next-generation sequencing (NGS), or protein-based testing workflows hands-free with the help of robotics arm.

Frequently Asked Questions About This Report